BIOMAT Database Logo BIOMAT Database Logo

Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement. 1978

W Orr, and J Varani, and P A Ward

Chemotactic factors for malignant neoplastic cells can be generated from either the fifth component of complement or from leukotactic fractions obtained from zymosanactivated serum. Digestion of the fifth component of complement by trypsin initially produced leukotactic activity, but as digestion continues, leukotactic activity is lost and tumor cell chemotactic activity is generated. Separation of the leukotactic activity is lost and tumor cell chemotactic activity is generated. Separation of the leukotactic activity and tumor cell chemotactic activity can be accomplished by gel filtration or isoelectric focusing. Gel filtration indicates that the tumor cell chemotactic factor has a molecular weight of approximately 8000 daltons. Tumor cell chemotactic activity can be generated by trypsinizing the leukotactic fractions isolated by isoelectric focusing. The responses of cultured Walker tumor cells or of Walker ascites tumor cells are dose-dependent and truly chemotactic. Cells from a murine malignant lymphoma do not respond to the complement-derived chemotactic factor for tumor cells, indicating that not all malignant cells share this functional property.

UI MeSH Term Description Entries
D007525 Isoelectric Focusing Electrophoresis in which a pH gradient is established in a gel medium and proteins migrate until they reach the site (or focus) at which the pH is equal to their isoelectric point. Electrofocusing,Focusing, Isoelectric
D008223 Lymphoma A general term for various neoplastic diseases of the lymphoid tissue. Germinoblastoma,Lymphoma, Malignant,Reticulolymphosarcoma,Sarcoma, Germinoblastic,Germinoblastic Sarcoma,Germinoblastic Sarcomas,Germinoblastomas,Lymphomas,Lymphomas, Malignant,Malignant Lymphoma,Malignant Lymphomas,Reticulolymphosarcomas,Sarcomas, Germinoblastic
D001769 Blood The body fluid that circulates in the vascular system (BLOOD VESSELS). Whole blood includes PLASMA and BLOOD CELLS.
D002279 Carcinoma 256, Walker A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed) Carcinosarcoma 256, Walker,Walker Carcinoma 256,Walker Carcinosarcoma 256
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002633 Chemotaxis The movement of cells or organisms toward or away from a substance in response to its concentration gradient. Haptotaxis
D002634 Chemotaxis, Leukocyte The movement of leukocytes in response to a chemical concentration gradient or to products formed in an immunologic reaction. Leukotaxis,Leukocyte Chemotaxis
D003182 Complement C5 C5 plays a central role in both the classical and the alternative pathway of COMPLEMENT ACTIVATION. C5 is cleaved by C5 CONVERTASE into COMPLEMENT C5A and COMPLEMENT C5B. The smaller fragment C5a is an ANAPHYLATOXIN and mediator of inflammatory process. The major fragment C5b binds to the membrane initiating the spontaneous assembly of the late complement components, C5-C9, into the MEMBRANE ATTACK COMPLEX. C5 Complement,Complement 5,Complement C5, Precursor,Complement Component 5,Precursor C5,Pro-C5,Pro-complement 5,C5, Complement,C5, Precursor,C5, Precursor Complement,Complement, C5,Component 5, Complement,Precursor Complement C5,Pro C5,Pro complement 5
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

W Orr, and J Varani, and P A Ward
Fifth component of complement (C5)-derived high-molecular-weight macrophage chemotactic factor in normal guinea pig serum.
December 1987, Inflammation,
W Orr, and J Varani, and P A Ward
Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement.
October 1968, Science (New York, N.Y.),
W Orr, and J Varani, and P A Ward
Detection of a complement-derived chemotactic factor for tumor cells in human inflammatory and neoplastic effusions.
January 1983, The American journal of pathology,
W Orr, and J Varani, and P A Ward
Biologically active peptides derived from the fifth component of complement.
January 1980, Progress in hemostasis and thrombosis,
W Orr, and J Varani, and P A Ward
A unique complement derived chemotactic factor for tumor cells.
October 1975, Proceedings of the National Academy of Sciences of the United States of America,
W Orr, and J Varani, and P A Ward
Chemotactic activity generated from the fifth component of complement by plasma kallikrein of the rabbit.
June 1981, The Journal of experimental medicine,
W Orr, and J Varani, and P A Ward
Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.
November 1984, The American journal of pathology,
W Orr, and J Varani, and P A Ward
Group B streptococci inhibit the chemotactic activity of the fifth component of complement.
November 1988, Journal of immunology (Baltimore, Md. : 1950),
W Orr, and J Varani, and P A Ward
Selective attraction of eosinophils and synergism between eosinophil chemotactic factor of anaphylaxis (ECF-A) and a fragment cleaved from the fifth component of complement (C5a).
June 1973, Immunology,
W Orr, and J Varani, and P A Ward
Factor XIII-dependent generation of 5th complement component(C5)-derived monocyte chemotactic factor coinciding with plasma clotting.
January 1992, Biochimica et biophysica acta,
Copied contents to your clipboard!